TNFSF10 and glioblastoma: Despite that several dozens of TRAIL-based fusion proteins were developed in the past few years, few of them are developed for brain tumor targeting, with the blood-brain barrier (BBB) being one of the important obstacles to the implementation of TRAIL-based preparations for the treatment of glioblastoma.